Edition:
United States

Spero Therapeutics Inc (SPRO.OQ)

SPRO.OQ on NASDAQ Stock Exchange Global Select Market

12.14USD
13 Jul 2018
Change (% chg)

-- (--)
Prev Close
$12.14
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
24,078
52-wk High
$19.00
52-wk Low
$9.66

Chart for

About

Spero Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on identifying, developing and commercializing novel treatments for MDR bacterial infections. The Company is developing a portfolio of novel product candidates, including SPR994, Potentiator Platform (SPR741 and SPR206), and SPR720.... (more)

Overall

No Ratios Available.

Financials

  SPRO.OQ Industry Sector
P/E (TTM): -- 85.48 32.76
EPS (TTM): -- -- --
ROI: -- 2.29 14.61
ROE: -- 3.86 16.34

Earnings vs. Estimates